Breaking News, Collaborations & Alliances

SQ Innovation and FIS Ink Agreement for Long-Term Supply of Pharma-Grade Furosemide

The furosemide API will be used for SQ Innovation products both current and in the pipeline.

Author Image

By: Patrick Lavery

Content Marketing Editor

SQ Innovation and FIS (Fabbrica Italiana Sintetici) have a strategic supply agreement to secure long-term availability of pharmaceutical-grade furosemide. Purpose of Furosemide API The furosemide active pharmaceutical ingredient (API) will be used for SQ Innovation products both current and in the pipeline. Specifically, this includes continued production of Lasix ONYU, a loop diuretic to treat edema in adult patients with heart failure. In 2025, the U.S. FDA approved this drug-device comb...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters